<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2005 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER III - NATIONAL RESEARCH INSTITUTES</span><br/>
<span style="font-size:10pt">Part C - Specific Provisions Respecting National Research Institutes</span><br/>
<span style="font-size:10pt">subpart 4 - national institute of arthritis and musculoskeletal and skin diseases</span><br/>
<span style="font-size:10pt">Sec. 285d-7 - Advisory Board</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_285d-7  usckey:420000000028500000000000d00070000 currentthrough:20060102 documentPDFPage:483 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER III/Part C/subpart 4/Sec. 285d-7 -->
<!-- itemsortkey:420AASL -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER III-NATIONAL RESEARCH INSTITUTES!@!Part C-Specific Provisions Respecting National Research Institutes!@!subpart 4-national institute of arthritis and musculoskeletal and skin diseases!@!Sec. 285d-7 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;285d&ndash;7. Advisory Board</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Establishment</h4>
<p class="statutory-body">The Secretary shall establish in the Institute the National Arthritis and Musculoskeletal and Skin Diseases Advisory Board (hereafter in this section referred to as the &ldquo;Advisory Board&rdquo;).</p>
<h4 class="subsection-head">(b) Membership; ex officio members</h4>
<p class="statutory-body">The Advisory Board shall be composed of twenty appointed members and nonvoting, ex officio members, as follows:</p>
<p class="statutory-body-1em">(1) The Secretary shall appoint&mdash;</p>
<p class="statutory-body-2em">(A) twelve members from individuals who are scientists, physicians, and other health professionals, who are not officers or employees of the United States, and who represent the specialties and disciplines relevant to arthritis, musculoskeletal diseases, and skin diseases; and</p>
<p class="statutory-body-2em">(B) eight members from the general public who are knowledgeable with respect to such diseases, including one member who is a person who has such a disease, one person who is the parent of an adult with such a disease, and two members who are parents of children with arthritis.</p>
<br class="Q04" />
<p class="statutory-body-block-1em">Of the appointed members at least five shall by virtue of training or experience be knowledgeable in health education, nursing, data systems, public information, or community program development.</p>
<p class="statutory-body-1em">(2) The following shall be ex officio members of the Advisory Board:</p>
<p class="statutory-body-2em">(A) the Assistant Secretary for Health, the Director of NIH, the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the Director of the Centers for Disease Control and Prevention, the Under Secretary for Health of the Department of Veterans Affairs, and the Assistant Secretary of Defense for Health Affairs (or the designees of such officers), and</p>
<p class="statutory-body-2em">(B) such other officers and employees of the United States as the Secretary determines necessary for the Advisory Board to carry out its functions.</p>
<h4 class="subsection-head">(c) Compensation</h4>
<p class="statutory-body">Members of the Advisory Board who are officers or employees of the Federal Government shall serve as members of the Advisory Board without compensation in addition to that received in their regular public employment. Other members of the Advisory Board shall receive compensation at rates not to exceed the daily equivalent of the annual rate in effect for grade GS&ndash;18 of the General Schedule for each day (including traveltime) they are engaged in the performance of their duties as members of the Advisory Board.</p>
<h4 class="subsection-head">(d) Term of office; vacancy</h4>
<p class="statutory-body">The term of office of an appointed member of the Advisory Board is four years. Any member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term. A member may serve after the expiration of the member's term until a successor has taken office. If a vacancy occurs in the Advisory Board, the Secretary shall make an appointment to fill the vacancy not later than 90 days after the date the vacancy occurred.</p>
<h4 class="subsection-head">(e) Chairman</h4>
<p class="statutory-body">The members of the Advisory Board shall select a chairman from among the appointed members.</p>
<h4 class="subsection-head">(f) Executive director, professional and clerical staff; administrative support services and facilities</h4>
<p class="statutory-body">The Secretary shall, after consultation with and consideration of the recommendations of the Advisory Board, provide the Advisory Board with an executive director and one other professional staff member. In addition, the Secretary shall, after consultation with and consideration of the recommendations of the Advisory Board, provide the Advisory Board with such additional professional staff members, such clerical staff members, and (through contracts or other arrangements) with such administrative support services and facilities, such information, and such services of consultants, as the Secretary determines are necessary for the Advisory Board to carry out its functions.</p>
<h4 class="subsection-head">(g) Meetings</h4>
<p class="statutory-body">The Advisory Board shall meet at the call of the chairman or upon request of the Director of the Institute, but not less often than four times a year.</p>
<h4 class="subsection-head">(h) Duties and functions</h4>
<p class="statutory-body">The Advisory Board shall&mdash;</p>
<p class="statutory-body-1em">(1) review and evaluate the implementation of the plan prepared under section 285d&ndash;1(a) of this title and periodically update the plan to ensure its continuing relevance;</p>
<p class="statutory-body-1em">(2) for the purpose of assuring the most effective use and organization of resources respecting arthritis, musculoskeletal diseases and skin diseases, advise and make recommendations to the Congress, the Secretary, the Director of NIH, the Director of the Institute, and the heads of other appropriate Federal agencies for the implementation and revision of such plan; and</p>
<p class="statutory-body-1em">(3) maintain liaison with other advisory bodies for Federal agencies involved in the implementation of such plan, the interagency coordinating committees for such diseases established under section 285d&ndash;4 of this title, and with key non-Federal entities involved in activities affecting the control of such diseases.</p>
<h4 class="subsection-head">(i) Subcommittees; establishment and membership</h4>
<p class="statutory-body">In carrying out its functions, the Advisory Board may establish subcommittees, convene workshops and conferences, and collect data. Such subcommittees may be composed of Advisory Board members and nonmember consultants with expertise in the particular area addressed by such subcommittees. The subcommittees may hold such meetings as are necessary to enable them to carry out their activities.</p>
<h4 class="subsection-head">(j) Annual report</h4>
<p class="statutory-body">The Advisory Board shall prepare an annual report for the Secretary which&mdash;</p>
<!-- PDFPage:484 --><p class="statutory-body-1em">(1) describes the Advisory Board's activities in the fiscal year for which the report is made;</p>
<p class="statutory-body-1em">(2) describes and evaluates the progress made in such fiscal year in research, treatment, education, and training with respect to arthritis, musculoskeletal diseases, and skin diseases;</p>
<p class="statutory-body-1em">(3) summarizes and analyzes expenditures made by the Federal Government for activities respecting such diseases in such fiscal year for which the report is made;</p>
<p class="statutory-body-1em">(4) contains the Advisory Board's recommendations (if any) for changes in the plan prepared under section 285d&ndash;1 of this title; and</p>
<p class="statutory-body-1em">(5) contains recommendations for expanding the Institute's funding of research directly applicable to the cause, diagnosis, early detection, prevention, control, and treatment of, and rehabilitation of children with arthritis and musculoskeletal diseases.</p>
<h4 class="subsection-head">(k) Termination of predecessor board; time within which to appoint members</h4>
<p class="statutory-body">The National Arthritis Advisory Board in existence on November 20, 1985, shall terminate upon the appointment of a successor Board under subsection (a) of this section. The Secretary shall make appointments to the Advisory Board established under subsection (a) of this section before the expiration of 90 days after November 20, 1985. The member of the Board in existence on November 20, 1985, may be appointed, in accordance with subsections (b) and (d) of this section, to the Advisory Board established under subsection (a) of this section.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title IV, &sect;442, as added Pub. L. 99&ndash;158, &sect;2, Nov. 20, 1985, 99 Stat. 852; amended Pub. L. 102&ndash;405, title III, &sect;302(e)(1), Oct. 9, 1992, 106 Stat. 1985; Pub. L. 102&ndash;531, title III, &sect;312(d)(7), Oct. 27, 1992, 106 Stat. 3504; Pub. L. 103&ndash;43, title VII, &sect;701(d), title XX, &sect;2008(b)(7), June 10, 1993, 107 Stat. 162, 211.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1993&mdash;Subsec. (a). Pub. L. 103&ndash;43, &sect;701(d)(1), inserted &ldquo;and Musculoskeletal and Skin Diseases&rdquo; after &ldquo;Arthritis&rdquo;.</p>
<p class="note-body">Subsec. (b). Pub. L. 103&ndash;43, &sect;&sect;701(d)(2), 2008(b)(7), substituted &ldquo;twenty&rdquo; for &ldquo;eighteen&rdquo; in introductory provisions, &ldquo;eight&rdquo; for &ldquo;six&rdquo; and &ldquo;including one member who is a person who has such a disease, one person who is the parent of an adult with such a disease, and two members who are parents of children with arthritis&rdquo; for &ldquo;including at least one member who is a person who has such a disease and one member who is a parent of a person who has such a disease&rdquo; in par. (1)(B), and &ldquo;Department of Veterans Affairs&rdquo; for &ldquo;Veterans&rsquo; Administration&rdquo; in par. (2)(A).</p>
<p class="note-body">Subsec. (j)(5). Pub. L. 103&ndash;43, &sect;701(d)(3), added par. (5).</p>
<p class="note-body">1992&mdash;Subsec. (b)(2)(A). Pub. L. 102&ndash;531 substituted &ldquo;Centers for Disease Control and Prevention&rdquo; for &ldquo;Centers for Disease Control&rdquo;.</p>
<p class="note-body">Pub. L. 102&ndash;405 substituted &ldquo;Under Secretary for Health&rdquo; for &ldquo;Chief Medical Director&rdquo;.</p>
<!-- field-end:amendment-note -->
<!-- field-start:terminationdate-note -->
<h4 class="note-head">Termination of Advisory Boards</h4>
<p class="note-body">Advisory boards established after Jan. 5, 1973, to terminate not later than the expiration of the 2-year period beginning on the date of their establishment, unless, in the case of a board established by the President or an officer of the Federal Government, such board is renewed by appropriate action prior to the expiration of such 2-year period, or in the case of a board established by the Congress, its duration is otherwise provided by law. See sections 3(2) and 14 of Pub. L. 92&ndash;463, Oct. 6, 1972, 86 Stat. 770, 776, set out in the Appendix to Title 5, Government Organization and Employees.</p>
<p class="note-body">Pub. L. 93&ndash;641, &sect;6, Jan. 4, 1975, 88 Stat. 2275, set out as a note under section 217a of this title, provided that an advisory committee established pursuant to the Public Health Service Act shall terminate at such time as may be specifically prescribed by an Act of Congress enacted after Jan. 4, 1975.</p>
<!-- field-end:terminationdate-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">References in Other Laws to GS&ndash;16, 17, or 18 Pay Rates</h4>
<p class="note-body">References in laws to the rates of pay for GS&ndash;16, 17, or 18, or to maximum rates of pay under the General Schedule, to be considered references to rates payable under specified sections of Title 5, Government Organization and Employees, see section 529 [title I, &sect;101(c)(1)] of Pub. L. 101&ndash;509, set out in a note under section 5376 of Title 5.</p>
<!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->


</body></html>